These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17286537)

  • 1. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
    van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
    Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.
    Muralidharan N; Sundaram R; Kodidela S; Chengappa KG; Mariaselvam CM; Misra DP; Negi VS
    Pharmacogenomics J; 2020 Apr; 20(2):342-349. PubMed ID: 31611592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.
    Davis LA; Polk B; Mann A; Wolff RK; Kerr GS; Reimold AM; Cannon GW; Mikuls TR; Caplan L
    Clin Exp Rheumatol; 2014; 32(3):324-32. PubMed ID: 24447348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population.
    Hashiguchi M; Tanaka T; Shimizu M; Tsuru T; Chiyoda T; Miyawaki K; Irie S; Takeuchi O; Hakamata J; Mochizuki M
    J Clin Pharmacol; 2016 Dec; 56(12):1563-1569. PubMed ID: 27146084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
    Yamamoto T; Shikano K; Nanki T; Kawai S
    Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in folylpolyglutamate synthase and gamma-glutamyl hydrolase and plasma homocysteine levels in the Singapore Chinese Health Study.
    Oppeneer SJ; Ross JA; Koh WP; Yuan JM; Robien K
    Mol Genet Metab; 2012 Jan; 105(1):73-8. PubMed ID: 22018726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells.
    Cheng Q; Wu B; Kager L; Panetta JC; Zheng J; Pui CH; Relling MV; Evans WE
    Pharmacogenetics; 2004 Aug; 14(8):557-67. PubMed ID: 15284538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
    Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
    Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
    Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Intracellular Metabolism of Methotrexate in Hepatocytes and Embryonic Kidney Cells based on Folylpolyglutamate Synthetase and Gamma-Glutamyl Hydrolase Expression.
    Jiang H; Yang J; Hou Y; Zhang K; Ren Y; Huang J; Li H; Cai T; Ouyang Z; Zhao J; Yu P
    Curr Drug Metab; 2023; 24(2):139-147. PubMed ID: 37038713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.
    Jekic B; Lukovic L; Bunjevacki V; Milic V; Novakovic I; Damnjanovic T; Milasin J; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Kovacevic L; Krajinovic M
    Eur J Clin Pharmacol; 2013 Mar; 69(3):377-83. PubMed ID: 22763757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency distribution of five SNPs in human
    Li M; Wang SM; Wu WS; Yan D; Zhang LP; Zheng HY
    Pharmazie; 2020 Apr; 75(4):142-146. PubMed ID: 32295690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
    Stamp LK; Hazlett J; Highton J; Hessian PA
    J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
    Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance.
    Cole PD; Kamen BA; Gorlick R; Banerjee D; Smith AK; Magill E; Bertino JR
    Cancer Res; 2001 Jun; 61(11):4599-604. PubMed ID: 11389096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.